Sign inCreate account

Report workspace tools

NCT02477202COMPLETEDanonymous

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

Sponsor

Source record

Memorial Sloan Kettering Cancer Center

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Epithelial Ovarian Cancer

Indication / condition

AI-normalized

Epithelial Ovarian Cancer

Intervention

Source record

Mirena® intra-uterine device (IUD)

Source & freshness

Source record

NCT ID

NCT02477202

Original source

ClinicalTrials.gov

Source last updated

Oct 16, 2023

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02477202

Title

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

Sponsor

Memorial Sloan Kettering Cancer Center

Status

COMPLETED

Phase

NA

Condition raw

Epithelial Ovarian Cancer

Condition normalized

Epithelial Ovarian Cancer

Modality raw

Epithelial Ovarian Cancer

Modality normalized

medical device

Target raw

Epithelial Ovarian Cancer

Target normalized

Epithelial Ovarian Cancer

Interventions

Mirena® intra-uterine device (IUD)

Public preview

Source record

This study evaluates the effect of the Mirena® IUD on cell proliferation in the fallopian tube fimbriae, which may serve as a biomarker for reduced risk of invasive epithelial ovarian cancer (IEOC) in women aged 35-50 undergoing risk-reducing surgeries.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02477202

Status

COMPLETED

Phase

NA

Sponsor

Memorial Sloan Kettering Cancer Center

Executive brief

Investment-Ready Snapshot

This study evaluates the effect of the Mirena® IUD on cell proliferation in the fallopian tube fimbriae, which may serve as a biomarker for reduced risk of invasive epithelial ovarian cancer (IEOC) in women aged 35-50 undergoing risk-reducing surgeries.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedOct 16, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02477202

Indication

Epithelial Ovarian Cancer

Modality

medical device

Target

Epithelial Ovarian Cancer

Intervention

Mirena® intra-uterine device (IUD)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.